Trial Search Results

Transanastomotic Tube for Proximal Esophageal Atresia With Distal Tracheoesophageal Fistula Repair

This trial will compare the effectiveness of two common surgical practices for Type C esophageal atresia repair: esophageal atresia (EA) with distal tracheoesophageal fistula (TEF). Infants with EA/TEF requiring surgical intervention will be recruited. Subjects will be randomized to either repair with or without transanstomotic tube (TT) during esophageal anastomosis creation. Primary outcome is symptomatic anastomotic stricture development requiring dilation within 12 months.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Phoenix Children's Hospital

Stanford Investigator(s):


  • Device: Transanastomotic Tube (5FR)
  • Other: No Transanastomotic Tube


Phase 4


Inclusion Criteria:

   - Infants diagnosed with type C esophageal atresia: proximal esophageal atresia and
   distal tracheoesophageal fistula

   - Primary repair of the esophageal atresia within the first six months of life

   - Minimum follow up of 1 year (12 months)

Exclusion Criteria:

   - Other types of esophageal atresia without esophageal anastomosis creation

   - Major anomaly that influences likelihood of developing primary outcome or affects
   surgical treatment considerations

Ages Eligible for Study

N/A - 6 Months

Genders Eligible for Study


Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Claudia Mueller, MD, PhD